Performance Evaluation of the VITEK2 and Sensititre Systems to Determine Colistin Resistance and MIC for Acinetobacter baumannii
- PMID: 35741297
- PMCID: PMC9221671
- DOI: 10.3390/diagnostics12061487
Performance Evaluation of the VITEK2 and Sensititre Systems to Determine Colistin Resistance and MIC for Acinetobacter baumannii
Abstract
Performances of the colistin antimicrobial susceptibility testing (AST) systems of Acinetobacter baumannii vary depending on the manufacturer, and data on colistin-resistant A. baumannii are limited. We evaluated the VITEK2 and Sensititre systems to determine colistin resistance and minimum inhibitory concentration (MIC) for A. baumannii isolated from a clinical microbiology laboratory. A total of 213 clinical A. baumannii isolates were tested, including 81 colistin-resistant A. baumannii. ASTs were performed using the VITEK2 and Sensititre systems according to the manufacturer's instructions. Reference MICs for colistin were determined using the manual broth microdilution method (BMD). The results of the two AST methods were compared with the BMD results. VITEK2 and Sensititre systems showed category agreements of 95.3% and 99.1%, respectively. VITEK2 had a relatively high very major error (VME) rate (9.9%). Sensititre reported higher MICs than the reference method for the susceptible isolates and showed low essential agreement. In conclusion, the automated systems investigated in this study showed good category agreements for colistin AST of A. baumannii. However, VITEK2 had a high VME rate, and Sensititre had differences in MIC results. Colistin AST remains a challenging task in the clinical laboratory.
Keywords: Acinetobacter baumannii; antimicrobial susceptibility test; colistin.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Korea Disease Control and Prevention Agency . National Antimicrobial Resistance Surveilance in Korea 2020 Annual Report. Korea Disease Control and Prevention Agency; Osong, Korea: 2021.
-
- Yoon E.J., Kim H.S., Woo H., Choi Y.J., Won D., Choi J.R., Kim Y.A., Jeong S.H. Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection. J. Antimicrob. Chemother. 2021;77:69–73. doi: 10.1093/jac/dkab363. - DOI - PubMed
-
- Pormohammad A., Mehdinejadiani K., Gholizadeh P., Nasiri M.J., Mohtavinejad N., Dadashi M., Karimaei S., Safari H., Azimi T. Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis. Microb. Pathog. 2020;139:103887. doi: 10.1016/j.micpath.2019.103887. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
